Authors
Latest:
Insights From Comprehensive Research on Epilepsy and Cognitive Decline: Ifrah Zawar, MDThe assistant professor of neurology at the University of Virginia talked about findings from a comprehensive study on epilepsy and mild cognitive impairment, which was recently presented at AES 2023. [WATCH TIME: 5 minutes]
Latest:
Air Pollution’s Impact on Cognitive Decline and the Neurotoxicity of Particulate Matter: Masashi Kitazawa, PhDThe associate professor of environmental and occupational Health at the University of California, Irvine, talked about the impact of concentrated particulate matter or air pollution on cognitive function in animal models. [WATCH TIME: 5 minutes]
Latest:
Preventing Secondary Stroke: Practical Application of Updated GuidelinesExperts provide a summary of the management of commonly encountered risk factors for secondary ischemic stroke and transient ischemic attack based on the newly published 2021 AHA/ASA recommendations.
Latest:
How Vidofludimus Calcium Addresses Unmet Treatment Needs in Multiple Sclerosis: Andreas Muehler, MD, MBAThe chief medical officer at Immunic provided clinical insight on the dual mechanism of action of vidofludimus calcium, and how its positioned as a treatment option across all MS subtypes. [WATCH TIME: 3 minutes]
Latest:
Challenges in Transitioning Care for Duchenne Muscular Dystrophy: Diana Castro, MDThe neuromuscular specialist at the Neurology & Neuromuscular Care Center discussed the pressing need to address the transition of care from pediatric to adult healthcare systems in Duchenne muscular dystrophy. [WATCH TIME: 6 minutes]
Latest:
Physical Therapy, Optimizing Function in Neuromuscular Diseases: Megan Iammarino, PT, DPTThe research physical therapist at Nationwide Children’s Hospital talked about the role of physical therapy in the changing landscape of care with neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 5 minutes]
Latest:
Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.
Latest:
Characterizing Real-World Outcomes With Eptinezumab in Migraine: Zubair Ahmed, MDThe neurologist from Cleveland Clinic discussed the importance of studying real-world outcomes in patients with migraine using CGRPs such as eptinezumab.
Latest:
The Future of Multiple Sclerosis TreatmentAhmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, share their hopes about the evolution of future mutiple sclerosis care and express their gratitude for the next generation of neurologists.
Latest:
The Paradigm Shift in Therapeutic Intervention for ALS: Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMSThe Bushell Chair of Neurology at the University of Sydney offered his perspective on phase 2 data of CNM-Au8 in amyotrophic lateral sclerosis and spoke to the advances that the field has made in recent years. [WATCH TIME: 3 minutes]
Latest:
Understanding Brain Differences in MRI Markers, Sleep-Disordered Breathing of Latino Individuals: Alberto Ramos, MD, MSPH, FAASMThe director of the Sleep Disorders program at the University of Miami discussed his research regarding the association of sleep disordered breathing and total brain volumes in Latino individuals. [WATCH TIME: 3 minutes]
Latest:
Efforts to Overcome Sleep Issues in Underserved Communities: Dayna Johnson, PhD, MPH, MSW, MSThe sleep epidemiologist and assistant professor at the Rollins School of Public Health at Emory University discussed the multi-level effort needed to improve sleep issues seen in individuals most impacted by social determinants of health. [WATCH TIME: 3 minutes]
Latest:
Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ CongressClinicians must be armed with fact-based information on all treatment options especially newer medications and technologies—good clinical care must be both patient-centric and knowledge-driven.
Latest:
AUPN Leading Edge Episode 3: What Your CEO Wants From YouAUPN Leading Edge Episode 3 features Clifton Gooch, MD, and Rich Sobieray, who discuss expectations for chairs in the academic health systems. [LISTEN TIME: 37 minutes]
Latest:
Managing Insomnia: Practical Advice for Community PhysiciansClosing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Latest:
Evolving Rehabilitation Strategies for Multiple SclerosisAhmed Obeidat, MD, PhD; Francois Bethoux, MD; and Nicholas C. Ketchum, MD, discuss recent advancements and future directions in rehabilitation strategies for multiple sclerosis.
Latest:
The Benefits of a New Therapy for Pompe Disease: Tahseen Mozaffar, MD, FAANOn Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]
Latest:
The Relationship Between Epstein-Barr Virus and Multiple SclerosisThe paradigm-shifting evidence of the link between MS and EBV does not exist in isolation. In fact, the relationship has been suspected for more than 40 years, and evidence therein has been accumulating over the past 2 decades.
Latest:
Adding Experience to the National Health Institute Council: Amy Brin, MSN, MA, PCNS-BCThe chief executive officer of the Child Neurology Foundation provided insight on her new position at the National Health Institute’s National Advisory Neurological Disorders and Stroke Council. [WATCH TIME: 4 minutes]
Latest:
Clinical Perspective of Insomnia in Sleep MedicineAlexander Scheer, MD, medical director at Scheer Medical Wellness, provided his medical perspective on insomnia in the clinical practice of sleep medicine.
Latest:
Preventing Epilepsy Through Antiseizure Medication in Tuberous Sclerosis Complex: Gabrielle Rushing, PhDThe director of research at the TSC Alliance spoke with us at the 2022 AES Conference about future research to be conducted on patients with TSC such as the PREVeNT trial. [WATCH TIME: 6 minutes]
Latest:
Future Outlook for Alzheimer’s DiseaseDrs Atri, Cohen, Sabbagh and McDade share their enthusiasm and optimism about the future outlook for Alzheimer’s disease.
Latest:
Connecting ALS: How New Drug Coverage Decisions Are MadeIn this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.
Latest:
Ana Pereira, MD: Repurposing Riluzole for Alzheimer DiseaseThe assistant professor of neurology and neuroscience at Mount Sinai Medical Center detailed the promise marked by the results of a recent pilot trial of riluzole in Alzheimer disease.
Latest:
Refining Alzheimer Treatment Through Biomarker-Based Patient Selection: Michael Woodward, MD, FRACP; Anthony Caggiano, MD, PhDThe head of dementia research at Austin Health and the chief medical officer at Cognition Therapeutics talked about recently presented phase 2 findings on CT1812, an investigational medicine for patients with mild to moderate Alzheimer disease, at CTAD 2024. [WATCH TIME: 5 minutes]
Latest:
CMSC Live: 2024 Annual Meeting Day 3Host Jeffrey Wilken, PhD, chats with Marijean Buhse, PhD, RN, NP-C, MSCN; Amy Sullivan, PsyD, ABPP; and John DeLuca, PhD, ABPP, FACRM, FAPA, FAPS, FNAN, about the third day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.
Latest:
A New Approach to Protein Misfolding in Parkinson DiseasePreviously, many promising treatments for PD have ultimately resulted in untenable adverse effects or in failure, but the evolving area of protein folding offers an opportunity to slow or reverse the neurodegenerative process.
Latest:
Improvements to the Detection, Psychosocial Aspects of Narcolepsy in Adolescents: Eric Zhou, PhDThe assistant professor of pediatrics at Harvard Medical School provided perspective on the care needs of adolescents and young adults with narcolepsy, and the importance of early detection of lingering issues. [WATCH TIME: 3 minutes]
Latest:
Proper Ways to Engage Underserved Populations in Pain Medicine: Burel Goodin, PhDThe professor of anesthesiology at Washington University in St. Louis provided perspective on the respect and approach that comes with conducting research in underserved or impoverished communities. [WATCH TIME: 4 minutes]
Latest:
Incorporation of Biomarkers, Synaptic Plasticity, in Treatment Paradigm for Alzheimer Disease: Alessio Travaglia, PhDThe director at the Foundation for the National Institutes of Health discussed relevant biomarkers for Alzheimer disease and their role as novel therapeutics continue to emerge. [WATCH TIME: 5 minutes]
